or Try an Advanced Search...

    Solid Tumor Cancers Stocks List

    Symbol Grade Name % Change
    NVCR B NovoCure Limited 2.21
    MNOV B MediciNova, Inc. -3.36
    CKPT B Checkpoint Therapeutics, Inc. -6.26
    NEO B NeoGenomics, Inc. -1.00
    GNTA C Genenta Science S.p.A. -3.37
    INAB D IN8bio, Inc. -13.26
    IMCR D Immunocore Holdings plc -0.83
    CRDF F Cardiff Oncology, Inc. -2.63
    SLXN F Silexion Therapeutics Ltd. -8.04
    NCNA F NuCana plc -0.79
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies Shell Companies
    Related Stock Lists: Cancer Medicine Oncology Biotechnology Clinical Medicine Chemotherapy Solid Tumors Biology Brain Tumor Cancer Immunotherapy Glioblastoma Leukemia Lymphoma Pancreatic Cancer Small Cell Lung Cancer Treatment Of Cancer Acute Leukemia Acute Myeloid Leukemia Adenosine Advanced Solid Tumors

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumor Cancers stocks.

    Symbol Grade Name Weight
    XHE A SPDR S&P Health Care Equipment 1.7
    HTEC A Robo Global Healthcare Technology and Innovation ETF 1.5
    XHS B SPDR S&P Health Care Services ETF 1.45
    CNCR F Loncar Cancer Immunotherapy ETF 1.43
    WDNA D WisdomTree BioRevolution Fund 1.38
    View all Solid Tumor Cancers ETFs...
    Compare ETFs
    Compare HTEC to CNCR Compare XHE to HTEC Compare XHE to XHS

        Solid Tumor Cancers Stocks Recent News

        Date Stock Title
        Dec 3 NVCR Novocure Stock Earns 96 RS Rating
        Dec 3 NVCR NVCR Stock Up as TTFields Therapy Meets Pancreatic Cancer Study Goals
        Dec 3 NVCR Zai Lab, Novocure announce PANOVA-3 trial met primary endpoint
        Dec 3 IMCR Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma
        Dec 2 NVCR Novocure seeks approval after pancreatic cancer wearable scores at Phase III
        Dec 2 NVCR Novocure Moves Pancreatic Cancer Treatment Forward With A 'First' Using TTFields
        Dec 2 NVCR Novocure Launches 31% After Pancreatic Cancer Treatment Succeeds
        Dec 2 NVCR NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients
        Dec 2 NVCR Novocure's Stock Skyrockets Over 32% Amid Groundbreaking Pancreatic Cancer Therapy Success
        Dec 2 NVCR Novocure therapy succeeds in pancreatic cancer trial
        Dec 2 NVCR Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
        Dec 2 NVCR Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
        Dec 2 INAB IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference
        Dec 2 NVCR Novocure device succeeds in pancreatic cancer study; FDA sets Cytokinetics decision date
        Nov 28 IMCR Does Immunocore (IMCR) Have the Potential to Rally 112.82% as Wall Street Analysts Expect?
        Nov 27 NVCR Novocure to Participate in Upcoming Investor Conferences
        Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies Shell Companies
        Related Stock Lists: Cancer Medicine Oncology Biotechnology Clinical Medicine Chemotherapy Solid Tumors Biology Brain Tumor Cancer Immunotherapy Glioblastoma Leukemia Lymphoma Pancreatic Cancer Small Cell Lung Cancer Treatment Of Cancer Acute Leukemia Acute Myeloid Leukemia Adenosine Advanced Solid Tumors
        Solid Tumor Cancers

        Solid tumor cancers are a type of cancer that forms in solid organs or tissues of the body. These tumors can be benign (non-cancerous) or malignant (cancerous). Solid tumor cancers can occur in any organ or tissue, including the brain, breast, colon, pancreas, and prostate. Treatment for solid tumor cancers typically involves surgery, chemotherapy, radiation, and/or targeted therapy.

        Browse All Tags